These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34879980)

  • 1. Clonal hematopoiesis and atherosclerotic cardiovascular disease: A primer.
    Zuriaga MA; Fuster JJ
    Clin Investig Arterioscler; 2023; 35(1):35-41. PubMed ID: 34879980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Role of Acquired Mutations and Clonal Hematopoiesis in Atherosclerosis　- Beyond Conventional Cardiovascular Risk Factors.
    Zuriaga MA; Fuster JJ
    Circ J; 2023 Feb; 87(3):394-400. PubMed ID: 34433749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
    Haring B; Wissel S; Manson JE
    Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease.
    Amorós-Pérez M; Fuster JJ
    Atherosclerosis; 2020 Mar; 297():120-126. PubMed ID: 32109665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors.
    Fuster JJ
    Thromb Res; 2022 May; 213 Suppl 1():S107-S112. PubMed ID: 36210552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal hematopoiesis and associated diseases: A review of recent findings.
    Asada S; Kitamura T
    Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
    Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
    Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal hematopoiesis and vascular disease.
    Amancherla K; Wells JA; Bick AG
    Semin Immunopathol; 2022 May; 44(3):303-308. PubMed ID: 35122117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
    Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
    J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Hematopoiesis and Cardiovascular Risk: Atherosclerosis, Thrombosis, and beyond.
    Izzi B; Fuster JJ
    Hamostaseologie; 2024 Feb; 44(1):13-20. PubMed ID: 38417801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease.
    Huang YC; Wang CY
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis.
    Polizio AH; Park E; Walsh K
    Curr Atheroscler Rep; 2023 Mar; 25(3):105-111. PubMed ID: 36808603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal hematopoiesis and cardiovascular diseases: role of JAK2V617F.
    Misaka T; Kimishima Y; Yokokawa T; Ikeda K; Takeishi Y
    J Cardiol; 2023 Jan; 81(1):3-9. PubMed ID: 35165011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
    Marnell CS; Bick A; Natarajan P
    J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal Hematopoiesis in Patients With Atherosclerotic Cardiovascular Disease: One Step Closer to the Clinical Scenario.
    Fuster JJ; Izzi B
    J Am Coll Cardiol; 2023 May; 81(20):2010-2012. PubMed ID: 37197844
    [No Abstract]   [Full Text] [Related]  

  • 16. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
    Jaiswal S; Natarajan P; Silver AJ; Gibson CJ; Bick AG; Shvartz E; McConkey M; Gupta N; Gabriel S; Ardissino D; Baber U; Mehran R; Fuster V; Danesh J; Frossard P; Saleheen D; Melander O; Sukhova GK; Neuberg D; Libby P; Kathiresan S; Ebert BL
    N Engl J Med; 2017 Jul; 377(2):111-121. PubMed ID: 28636844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A feedback loop: Interactions between Inflammatory Signals and Clonal Hematopoiesis in Cardiovascular Disease.
    Li J; Wang C; Liu J; Yu Y; Liu Y; Peng Q; Liu H; Guan X
    Mol Biol Rep; 2021 Apr; 48(4):3785-3798. PubMed ID: 33987748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential.
    Yu X; Qian N; Wang Y
    Mol Biol Rep; 2023 Mar; 50(3):2813-2822. PubMed ID: 36595120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells.
    Kandarakov O; Belyavsky A
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.
    Cobo I; Tanaka T; Glass CK; Yeang C
    Curr Opin Hematol; 2022 Jan; 29(1):1-7. PubMed ID: 34654019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.